Related Experiment Video
Updated: Jul 12, 2026

10:07
Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
66.3K
Granuloma Annulare Exhibits Mixed Immune and Macrophage Polarization Profiles with Spatial Transcriptomics
Chitrasen Mohanty1, Chandra K Singh2, Joseph A Daccache3
1Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
The Journal of Investigative Dermatology
|June 6, 2024
Summary
Granuloma annulare (GA) involves complex immune signaling and macrophage polarization. Spatial transcriptomics reveals key inflammatory drivers like IFN-γ, TNF, and IL-32 in GA skin lesions.
Area of Science:
- Dermatology
- Immunology
- Genomics
Background:
- Granuloma annulare (GA) is an idiopathic skin condition with granulomatous inflammation.
- The molecular drivers of macrophage activation in GA are poorly understood.
- GA lacks FDA-approved therapies, impacting patient quality of life.
Purpose of the Study:
- To explore the spatial gene expression landscape of Granuloma annulare.
- To elucidate the molecular composition and immune microenvironment of GA.
- To identify potential therapeutic targets for GA.
Main Methods:
- Spatial transcriptomics was employed to profile gene expression in skin lesions from 6 GA patients.
- Analysis focused on identifying localized gene expression patterns and immune cell characteristics.
Main Results:
- Findings revealed mixed T helper 1 and T helper 2 immune signals within the GA microenvironment.
- Spatially distinct M1 and M2 macrophage polarization patterns were observed.
- Interferon-gamma (IFN-γ), Tumor Necrosis Factor (TNF), and Interleukin-32 (IL-32) were identified as key regulators and drivers of inflammation.
Conclusions:
- Spatial transcriptomics data indicate mixed immune responses and macrophage polarization in GA.
- IFN-γ, TNF, and IL-32 are implicated as crucial mediators of granulomatous inflammation in GA.
- This study provides a foundation for understanding GA pathogenesis and developing targeted therapies.

